Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

G1 Therapeutics, Inc. GTHX

Set alert

Price alert · GTHX

All alert types
7.16 0.00 0.00%

As of Sep 17, 3:56 PM ET

7.14 Day range 7.16

52-week range unavailable

Open
7.15
Prev close
7.16
Mkt cap
377.75M
Vol
1.10M
Avg vol
0
EPS
0.00
P/E
0.00
Div yield
0.00%
More statistics
Low
7.14
High
7.16
Forward P/E
0.00
Beta
1.68
Short ratio
1.01
Inst. own
54.62%
Dividend
0.00
Ex-div date
Earnings
Nov 6, 2024
50-d avg
5.84
200-d avg
4.10
1y target
7.15

6M chart

Chart tools
Interval
1m5m15m30m

Events in this range
  • May 1, 2024Earnings: —; estimate -0.19; surprise —%
  • Aug 8, 2024Earnings: —; estimate -0.17; surprise —%
Signals (21)
NameDateAgo
MACD: Sell SignalAug 23, 20242 years ago
RSI: OverboughtAug 7, 20242 years ago
RSI: OverboughtJul 31, 20242 years ago
RSI: OverboughtJul 25, 20242 years ago
SMA: BullishJul 22, 20242 years ago
SMA: BearishJul 19, 20242 years ago
SMA: BullishJul 18, 20242 years ago
RSI: OverboughtJul 18, 20242 years ago
SMA: BullishJul 16, 20242 years ago
MACD: Buy SignalJul 1, 20242 years ago
RSI: OversoldJun 14, 20242 years ago
RSI: OversoldMay 29, 20242 years ago
SMA: BearishMay 28, 20242 years ago
SMA: BearishMay 23, 20242 years ago
MACD: Sell SignalMay 22, 20242 years ago
MACD: Buy SignalMay 6, 20242 years ago
SMA: BearishApr 29, 20242 years ago
MACD: Sell SignalApr 15, 20242 years ago
RSI: OverboughtApr 9, 20242 years ago
RSI: OverboughtApr 3, 20242 years ago

Newest 20 of 21.

Analyst view

Consensus: hold

Hold
Price target (mean) 7.15
Ratings (0m) 4 4 buy · 0 hold · 0 sell
  • Strong buy1
  • Buy3
  • Hold0
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 4
  • 1 month ago 6
  • 2 months ago 6
  • 3 months ago 4

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

GTHX analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-0.09-0.13 – -0.06-0.35+74.3%18.80M+52.8%2
Next quarter-0.06-0.11 – -0.01-0.21+71.4%20.83M+40.1%2
Current year-0.48-0.59 – -0.37-0.93+48.4%71.61M-13.2%2
Next year0.00-0.03 – 0.03-0.48+100.0%92.66M+29.4%2

Upgrades and downgrades

The latest rating changes

GTHX analyst upgrades and downgrades
DateFirmActionFromTo
Oct 5, 2023JP MorganDowngradeNeutralUnderweight
Aug 2, 2023WedbushReiteratedOutperformOutperform
Aug 2, 2023HC Wainwright & Co.ReiteratedBuyBuy
Aug 1, 2023EF HuttonReiterated—Buy
Aug 1, 2023NeedhamMaintainedBuyBuy
Jun 25, 2023HC Wainwright & Co.ReiteratedBuyBuy
Jun 4, 2023HC Wainwright & Co.ReiteratedBuyBuy
Jun 4, 2023NeedhamReiteratedBuyBuy
May 3, 2023HC Wainwright & Co.Reiterated—Buy
May 3, 2023Raymond JamesMaintained—Outperform
Apr 18, 2023NeedhamReiterated—Buy
Mar 1, 2023HC Wainwright & Co.Reiterated—Buy
Feb 13, 2023NeedhamMaintained—Buy
Feb 13, 2023HC Wainwright & Co.Maintained—Buy
Feb 12, 2023EF HuttonMaintained—Buy
Jan 29, 2023JP MorganUpgradeUnderweightNeutral
Jan 4, 2023EF HuttonInitiated—Buy
Jan 2, 2023NeedhamMaintained—Buy
Nov 1, 2022HC Wainwright & Co.Maintained—Buy
Sep 15, 2022WedbushMaintained—Outperform
Aug 3, 2022NeedhamMaintained—Buy
May 4, 2022NeedhamMaintained—Buy
Nov 3, 2021JP MorganDowngradeNeutralUnderweight
Nov 3, 2021HC Wainwright & Co.Maintained—Buy
Nov 3, 2021Raymond JamesMaintained—Outperform
Sep 29, 2021JP MorganDowngradeOverweightNeutral
Aug 31, 2021Roth CapitalMaintained—Buy
Feb 24, 2021NeedhamMaintained—Buy
Aug 5, 2020WedbushMaintained—Outperform
May 11, 2020JP MorganMaintained—Overweight